Cellspect

Morioka, Japan · Founded 2014 · Privately Held (backing)

Developer of in-vitro diagnostic agents and medical devices designed to offer the prognosis of endometriosis progression. Cellspect is based in Morioka, Japan and was founded in 2014. Its last reported valuation was $142 million in May 2019. It has raised $22.6 million.

Last reported valuation

$142.1M

Oct 2026

Priced at

—

Total raised

$22.6M

Last round

—

How much has Cellspect raised?

$22.6Macross 0 recorded rounds

Free account

More of Cellspect with a free account

·The complete investor list: 15 names
·Watch Cellspect: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Cellspect investors

15 investors are on record for Cellspect, including Mitsubishi UFJ Capital, FASTAR, MCP Partners and Tokyo University of Science Investment Management.

For fundraisers

Raising for a company like Cellspect?

15 investors have backed Cellspect.

See all 15 investors →

Frequently asked about Cellspect

How much has Cellspect raised?: Cellspect has raised $22.6M in total across 0 recorded funding rounds.